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Abstract
Pancreastatin (PST), a chromogranin A derived peptide with an array of effects in different tissues, has a role as a
counterregulatory hormone of insulin action in hepatocytes and adipocytes, regulating glucose, lipid and protein metabolism.
We have previously characterized PST receptors and signaling in rat hepatocytes, in which PST functions as a calcium-
mobilizing hormone. In the present work we have studied PST receptors as well as the signal transduction pathways
generated upon PST binding in adipocyte membranes. First, we have characterized PST receptors using radiolabeled PST as
a ligand. Analysis of binding data indicated the existence of one class of binding sites, with a Bmax of 5 fmol/mg of protein
and a Kd of 1 nM. In addition, we have studied the G protein system that couples the PST receptor by Q-35S-GTP binding
studies. We have found that two G protein systems are involved, pertussis toxin-sensitive and -insensitive respectively.
Specific anti-G protein K subtype sera were used to block the effect of pancreastatin receptor activation. GKq=11 and to a
lesser extent GKi1;2 are activated by PST in rat adipocyte membranes. On the other hand, adenylate cyclase activity was not
affected by PST. Finally, we have studied the specific phospholipase C isoform that is activated in response to PST. We have
found that PST receptor is coupled to PLC-L3 via GKq=11 activation in adipocyte membranes. ß 1999 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Pancreastatin (PST) [1] is a chromogranin A
(CGA) derived peptide [2], which is present through-
out the neuroendocrine system [3]. CGA has a rec-
ognized role as a precursor of biologically active pep-
tides [3^5]. PST was ¢rst described as an inhibitor of
insulin secretion [1] but many di¡erent e¡ects were
then reported (see [6] for review). However, the best
characterized e¡ect of PST has been studied in the
rat liver [7], where we found a counterregulatory ef-
fect on insulin action [8]. Thus, we found that PST
had a calcium-dependent glycogenolytic e¡ect in rat
hepatocytes [9^11] and an inhibitory e¡ect on insulin
stimulated glycogen synthesis [8]. Moreover, we
studied the mechanism of PST action in the rat liver
[12^14] and described for the ¢rst time the character-
ization of PST receptors [15,16]. PST receptors seem
to be coupled to a pertussis toxin-insensitive G pro-
tein of the Kq=11 family [17,18], which in turn leads to
the activation of phospholipase C (PLC) in the hep-
atocyte plasma membrane [14,18].
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Recently, we have found that PST has a biological
e¡ect in isolated rat adipocytes [19], another insulin
target. Thus, PST has a lipolytic e¡ect and inhibits
insulin action. PST partially blocked insulin-stimu-
lated glucose transport and metabolism, and inhib-
ited insulin-dependent lipogenesis in a dose-depend-
ent manner and within a physiological range of
concentrations. In order to characterize the mecha-
nism of PST action in the adipocyte, we have studied
PST receptors as well as the signal transduction
pathways generated upon PST binding in membranes
from adipose tissue.
2. Materials and methods
2.1. Materials
Rat [Tyr0]pancreastatin was synthesized by Chiron
Technologies (Clayton, Vic., Australia) and radioio-
dinated with 125I (Amersham Radiochemicals, UK)
by the chloramine T method [20] to a speci¢c activity
of 1500 Ci/mmol and puri¢ed by gel ¢ltration (Se-
phadex G-50) [15]. Bacitracin, leupeptin, TLCK,
PMSF, pepstatin, aprotinin, dithiothreitol (DTT),
bovine serum albumin (BSA) (fraction V) were
from Sigma (Alcobendas, Madrid). GTP, GDP, Q-
S-GTP, GMP-P(NH)P and other nucleotides were
from Boehringer Mannheim (Barcelona, Spain).
Electrophoretic chemicals and molecular weight
standards were from Novex (San Diego, CA). Rabbit
anti sera against Lcommon, Ki1;2, Ko;i3 and Kq=11 sub-
units of G proteins were from DuPont NEN (Du
Pont de Nemours, Germany). Antisera against the
L1, L2, L3 and L4 isoforms of PLC were from Santa
Cruz (Santa Cruz, CA). Q-35S-GTP (1000 Ci/mmol)
was from Amersham Iberica (Madrid, Spain).
2.2. Preparation of rat adipocyte membranes
Animals used were male Wistar rats (150^200 g)
fed ad libitum. Rats were killed by decapitation and
epididymal fat pads were homogenized in 20 mM
HEPES, pH 7.4, containing 1 mM EDTA, 0.01%
bacitracin, 0.1 mM PMSF, 10 Wg/ml aprotinin, 10
Wg/ml leupeptin, 5 Wg/ml pepstatin, 10 Wg/ml TLCK
and 10 Wg/ml aprotinin. After centrifugation for 10
min at 1800Ug and 4‡C, the infranatant was col-
lected and centrifuged for 30 min at 50 000Ug and
4‡C. The supernatant was discharged and the pellet
of crude membranes was washed by suspension and
centrifugation in the same bu¡er lacking EDTA.
Protein concentration was determined by the Bio-
Rad procedure [21], using bovine serum albumin as
standard.
2.3. Binding of 125I-pancreastatin to adipocyte
membranes
Binding to the membrane receptors was performed
with the radiolabeled rat pancreastatin analog [125I-
Tyr0]pancreastatin (1500 Ci/mmol speci¢c activity) as
previously described [15]. Speci¢c binding repre-
sented about 2.5% of total radioactivity, and non-
speci¢c binding represented 30^40% of total binding.
Non-speci¢c binding was subtracted from the total
binding to calculate the speci¢c binding. Scatchard
analysis of binding data from radioligand displace-
ment was performed with the LIGAND software
[15,16].
2.4. Pertussis toxin pretreatment of rat adipose
membranes
The treatment of membranes with thiol-preacti-
vated pertussis toxin was carried out as previously
described [14]. Brie£y, membranes were incubated
with thiol-preactivated pertussis toxin for 1 h at
23‡C in 25 mM Hepes bu¡er (pH 7.4) containing
5 mM MgCl2, 10 mM NAD, 1 mM ATP, 2 mM
creatine phosphate, 0.1 mg/ml creatine kinase and
0.1 mM GTP. Control membranes were treated in
identical manner, except that there was no toxin
present in the incubation bu¡er. The membrane sus-
pension was then centrifuged and the pellet washed
twice and ¢nally resuspended in HEPES bu¡er (20
mM, pH 7.5), containing bacitracin (200 Wg/ml) and
PMSF (0.1 mM).
2.5. Q-35S-GTP binding assay
GTP binding assay was conducted at 23‡C in a
bu¡er consisting of 150 mM NaCl, 5 mM MgCl2,
0.1 mM EDTA, 1 mM DTT, 1034 M GDP, and
10 mM Tris, pH 7.5, containing 0.5 nM Q-35S-GTP
(0.1 WCi per assay tube) [22^24]. The reaction was
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started by the addition of adipose membranes (100
Wg), and stopped at di¡erent times by adding 1 ml of
cold bu¡er. After centrifugation at 15 000Ug at 4‡C
and two washes with cold bu¡er, the pellet was dis-
solved in scintillation cocktail and counted in a scin-
tillation counter (Wallac 1409, Turku, Finland).
Non-speci¢c binding was determined in the presence
of 1035 M cold Q-S-GTP. All assays were performed
in quadruplicate. Blocking experiments with antisera
were performed by the addition of the speci¢c anti-
sera (1/100 ¢nal dilution) to the adipocyte mem-
branes and incubation for 60 min at 23‡C with gentle
agitation as previously described [23^25,17,18].
2.6. Adenylate cyclase assay
Adenylate cyclase was assayed as previously de-
scribed for rat liver membranes [13]. The incubation
medium contained 50 mM Tris-HCl bu¡er (pH 7.5),
bovine serum albumin (2 mg/ml), bacitracin (0.2 mg/
ml), 5 mM MgCl2, 1 mM 3-isobutyl-1-methylxan-
thine, 0.1 mM ATP and an ATP regenerating system
in an incubation medium [13]. Membranes were in-
cubated at 30‡C for 15 min and the reaction was
stopped by adding ice-cold ethanol. The proteins
were pelleted and the cAMP was determined in the
dried supernatant by an enzyme immunoassay (EIA)
system (kit from Amersham Pharmacia Biotech
(Buckinghamshire, UK).
2.7. Phospholipase C assay
PLC activity from rat adipose membranes was as-
sayed as previously described for rat liver membranes
[13]. IP3 was determined by a radioreceptor assay
from Amersham Pharmacia Biotech, using D-myo-in-
ositol 1,4,5-triphosphate[3H] as a tracer. G protein
and PLC antibody pretreatments were performed
by the addition of the speci¢c antisera (1/100 ¢nal
dilution) to the membranes and incubation for 60
min at 23‡C with gentle agitation as previously de-
scribed for endothelin B [26], thromboxane A2 [27],
and angiotensin II [28] receptors.
2.8. Immunodetection of K subunits of GTP-binding
proteins and PLC-L isoforms
Adipose membranes were denatured with Laemmli
bu¡er and run on an SDS-PAGE (8^16%). Proteins
were electrophoretically transferred onto nitrocellu-
lose membranes. The membranes were ¢rst incubated
with anti-Ki1;2, anti-Kq=11, or anti-PLC-L isoform,
further incubated with second antibody conjugated
with horseradish peroxidase and developed by the
Amersham enhanced chemiluminescence (ECL-Plus)
detection system [29].
3. Results
3.1. Binding properties of pancreastatin with adipose
membranes
Using 125I-labeled rat PST, we examined the bind-
ing characteristics of PST in rat adipocyte mem-
branes. The speci¢c high a⁄nity binding of 125I-
PST was dependent on temperature and pH (not
shown), reaching a maximum at 15‡C, 90 min and
pH 7.4 (Fig. 1A), and optimal protein concentration
of 400 Wg/ml (Fig. 1B). Under these conditions bind-
ing of PST was saturable (Fig. 2). As shown in Fig.
2A, rat PST in the concentration range between
10310 and 1038 M competitively inhibited the bind-
ing of 125I-PST to adipocyte membranes. Scatchard
analysis of the data gave a straight line, indicating
the presence of a single site with a dissociation con-
stant (Kd) of 1 nM and a maximum concentration of
binding sites at 5 fmol/mg protein. Taking into ac-
count the amount of membrane protein obtained
from each rat, which ranged 1 þ 0.2 mg, and consid-
ering the number of adipocytes from the two fat pads
of each rat, about 3U106 cells, the estimated num-
bers of binding sites averaged about 1000/cell.
When membranes were incubated with increasing
concentrations of the non-hydrolyzable nucleotide
GMP-P(NH)P, binding of the tracer was reduced
in a dose-dependent manner (Fig. 2B), suggesting
that PST receptors are coupled to G proteins in the
plasma membrane of the adipocyte.
3.2. Pancreastatin stimulation of G protein activation
We next determined PST receptor-mediated activa-
tion of G proteins by measuring the increase in Q-35S-
GTP binding elicited by PST in rat adipocyte mem-
branes. The signal was time-dependent, and maximal
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response was achieved at 10 min and 23‡C (Fig. 3A).
Under these incubation conditions, PST induced sig-
nal was dose-dependent, with half-maximal e¡ect ob-
served at 0.3 nM and maximal e¡ect at 1038 M (Fig.
3B). Pretreatment of membranes with pertussis toxin
partially inhibited (about 25%) PST stimulated GTP
binding to rat adipocyte membranes (Table 1), sug-
gesting that both pertussis toxin-sensitive and -insen-
sitive G proteins were activated upon PST binding.
To further examine the coupling of PST receptors
Fig. 2. (A) Inhibition of 125I-PST binding to adipocyte mem-
branes by unlabeled PST. Membranes were incubated with 125I-
PST and increasing concentrations of unlabeled PST under
standard conditions. Data are means þ S.E.M. from four inde-
pendent experiments run in triplicate. Inset, Scatchard analysis
of the PST binding data. (B) Inhibition of binding of 125I-PST
by the nucleotide analog GMP-P(NH)P. Rat adipose mem-
branes were incubated with the tracer and increasing concentra-
tions of GMP-P(NH)P. Data are means þ S.E.M. from four
separate experiments run in triplicate.
Fig. 1. Time and protein concentration dependence on PST
binding in adipose membranes. (A) Relative speci¢c binding of
125I-PST to rat fat membranes (400 Wg/500 Wl) as a function of
time at 15‡C. Data are shown as means þ S.E.M. from four in-
dependent experiments. (B) Relative speci¢c binding of 125I-PST
to adipose membranes to increasing concentrations of rat adi-
pocyte membranes during 90 min at 15‡C. Data are means
þ S.E.M. from four separate experiments.
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to speci¢c subtypes of G proteins, we incubated rat
adipose membranes with anti-GK protein antibodies
before assaying for Q-35S-GTP binding (Fig. 3C).
Binding of anti C-terminal antibodies seems to func-
tionally uncouple receptors and G proteins. Thus,
anti-GKq=11 serum inhibited PST-induced GTP bind-
ing about 85%, whereas anti-GKi1;2 serum inhibited
PST-induced GTP binding about 15%. On the other
hand, preimmune serum was used as control and it
had no e¡ect on PST-stimulated GTP binding (Fig.
3C). Other GK antisera (anti-GKo;i3) did not block
the e¡ect of PST (not shown). The presence of these
G protein K subunits in adipose tissue was checked
by speci¢c immunoblot (Fig. 4).
Table 1
E¡ect of pertussis toxin (PT) pretreatment of rat adipose mem-
branes on Q-35S-GTP binding stimulated by PST
Q-35S-GTP binding (fmol/mg protein)
Control membranes PT-treated membranes
Basal 65 þ 7 57 þ 8
PST (10 nM) 102 þ 82 82 þ 7*;2
Data are means þ S.E.M. (n = 4).
*P6 0.05 vs. control membranes.
2P6 0.01 vs. basal conditions.
Fig. 3. PST stimulates Q-35S-GTP binding to rat adipose mem-
branes. Blocking by GK speci¢c antisera. (A) Rat adipose mem-
branes were incubated with Q-35S-GTP in the presence (a) or
absence (b) of PST (1038 M) and the binding was determined
as described in Section 2 at di¡erent time points. Data are
means þ S.E.M. (n = 4) of the GTP binding activity assay run in
quadruplicate. (B) Concentration dependence of the PST-stimu-
lated GTP binding to rat adipose membranes. Membranes were
incubated at 23‡C for 10 min in the presence of increasing con-
centrations of PST to determine GTP binding activity as de-
scribed in Section 2. The values of each experiment were based
on quadruplicate tubes. Data are means (n = 4) þ S.E.M. of the
increase in GTP binding activity above control levels. (C) Basal
(3) and 10 nM PST-stimulated (+) GTP binding to adipose
membranes was measured in the absence or presence of prein-
cubation for 1 h with di¡erent blocking sera: anti-GKq=11,
GKi1;2, or preimmune sera (control). Data are means þ S.E.M.
of four di¡erent experiments run in quadruplicate. *P6 0.05,
**P6 0.001, signi¢cant di¡erences versus control.
6
Table 2
E¡ect of PST on adenylate cyclase activity
Condition Cyclic AMP production (pmol/min/mg)




GTP (1035 M) 17.0 þ 1.1*
Glucagon (1037 M) 18.0 þ 1.3*
Adrenaline (1036 M) 22.6 þ 1.5*
Forskolin (1034 M) 25.5 þ 1.0*
Data are means þ S.E.M. (n = 4).
*P6 0.005 vs. control.
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3.3. Pancreastatin e¡ect on adenylate cyclase activity
in adipose membranes
PST did not a¡ect basal activity of membrane-
bound adenylate cyclase in the presence of the phos-
phodiesterase inhibitor 3-isobutyl-1-methylxanthine
(Table 2). Positive controls of increased production
of cAMP were included in the assay by stimulating
adenylate cyclase directly with forskolin, by stimula-
tion of Gs with GTP, and by receptor-mediated
mechanism with glucagon and adrenaline.
3.4. Pancreastatin stimulation of phospholipase C in
adipose membranes
We have previous data showing that PST stimu-
lates PLC activity in plasma liver membranes in-
creasing the production of IP3 and diacylglycerol
[13,14]. Similarly, PST dose-dependently stimulated
PLC activity in adipocyte membranes, as assessed
by measuring IP3 production (Fig. 5A). The previous
data of GTP binding suggested the functional asso-
ciation of PST receptors with a pertussis toxin-insen-
sitive G protein, i.e. belonging to the Gq=11K family,
and it prompted us to check whether this G protein
might couple PST receptor to the activation of PLC
also in adipocyte membranes. We found that this
stimulatory e¡ect of PST on PLC activity was com-
pletely inhibited by anti-Gq=11K sera, whereas preim-
mune sera had no e¡ect (Fig. 5B). Anti-Gi1;2K and
anti-GLcommon sera failed to block PST stimulated
PLC activity, even though PST can activate GKi1;2.
This result demonstrates that the activation of the
e¡ector PLC by the PST receptor is mediated by
Gq=11K protein rather than LQ dimer released upon
Gi1;2K activation.
We have studied previously the speci¢c PLC-L iso-
enzymes involved in PST response and the speci¢c
Fig. 5. (A) Dose-dependent e¡ect of PST on PLC activity in
rat adipose membranes. IP3 production was measured as de-
scribed in Section 2. (B) Coupling of PST receptors to PLC via
GKq=11 protein. PLC activity was measured with or without
PST (10 nM) in the presence of anti-GK and -GL subunits.
Control experiments were performed in the presence of preim-
mune sera. (C) E¡ect of antibodies against PLC L isoforms (L1,
L2, L3) on the activation of PLC by PST. Rat adipose mem-
branes were incubated with (+) or without (3) PST (10 nM)
after pretreatment with di¡erent anti-PLC antibodies or preim-
mune serum (control). Data are means þ S.E.M. (n = 4).
*P6 0.001 compared with control.
Fig. 4. Expression of Kq=11 and Ki1;2 subunits of G proteins in
rat adipocyte membranes. Rat adipose membranes were dena-
tured and subjected to SDS-PAGE (80 Wg/lane) and immuno-
blotted as described in Section 2.
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GK subunit that mediates the PLC-L activation in rat
liver membranes [18]. In the present work, we have
also employed antibodies raised against the C-termi-
nal speci¢c sequences of each PLC-L isoform to
block the agonist-mediated activation of PLC in rat
adipose membranes, as previously described [18,30],
to sort out the speci¢c PLC-L isoform activated by
PST stimulation. As shown in Fig. 5C only anti-
PLC-L3 serum was able to block the PST (10 nM)
response in rat adipose membranes, whereas anti-
PLC-L1 and anti-PLC-L2 had no signi¢cant e¡ect
on PST stimulated PLC activity. These results dem-
onstrate the preferential stimulation of PLC-L3 by
PST receptor in spite of the fact that the three iso-
forms are present in rat adipocyte membranes, as
assessed by speci¢c immunoblots (Fig. 6). PLC-L4
was not found in adipose membranes (data not
shown).
4. Discussion
Previous data in rat hepatocytes have supported
the hypothesis of PST considered as a counterregu-
latory peptide of insulin action on glucose metabo-
lism [6,8,31,32]. Moreover, PST can also modulate
insulin receptor signaling in HTC, rat hepatoma cells
[33], by interrupting the stimulation of early signaling
events. The counterregulatory e¡ect of PST on insu-
lin action in rat adipocytes, which we have recently
described [19], may contribute to an overall e¡ect of
PST producing insulin resistance. Thus, the PST ef-
fect on insulin secretion by the L cell [1] and insulin
action in both the hepatocyte and the adipocyte has
raised the hypothesis of a role of PST in insulin
resistance syndromes [6,31,32]. In fact, high PST-
like plasma levels have been found in type 2 diabetes
[34], gestational diabetes [35] and essential hyperten-
sion [36,37], correlating with catecholamine levels.
In this paper, we have further investigated the
mechanisms of pancreastatin action in rat adipo-
cytes, by studying the pharmacology of PST binding
sites in adipose membranes, as well as the signaling
machinery activated upon PST binding.
We have previously described the presence of PST
receptors in rat liver membranes, and studied its
function and characterization [15,16]. Here, we
have found similar, albeit distinct characteristics in
PST receptors from rat adipose membranes. Thus,
the a⁄nity of the receptor is slightly lower but also
in the nanomolar range (Kd, 1 nM, versus 0.3 nM in
liver membranes), whereas the binding capacity is
lower (5 fmol/mg protein, versus 15 fmol/mg protein
in liver membranes) yielding a total number of bind-
ing sites (700^1000/cell) about 5 times lower than
that observed in liver membranes (about 4000/cell).
The sensitivity of the PST binding to guanine nucleo-
tide is comparable to that observed in liver mem-
branes [15], and suggested that PST receptor should
be coupled to G proteins also in adipose membranes.
We had also previous data suggesting that PST
receptors are coupled to phospholipase C activation
by interacting with some G proteins in rat liver mem-
branes [13]. Furthermore, we have previously shown
indirect evidence of the involvement of a pertussis
toxin-insensitive G protein that might mediate the
activation of phospholipase C [13] and, subsequently,
the increase in cytosolic free calcium [12] and the
activation of protein kinase C in the rat liver [14].
Moreover, the speci¢c pertussis toxin-insensitive G
protein stimulated by PST in liver membranes seems
to belong to the GKq=11 family [17,18,24]. On the
other hand, a GKi1;2 protein is also activated upon
PST stimulation in rat liver membranes [24],
although to a lesser extent. In this report, we ex-
plored the speci¢c activation of G proteins by PST
receptors in rat adipose membranes. First, we dem-
onstrated that PST stimulated GTP binding to the
adipose membranes in a dose-dependent manner.
This dose-response e¡ect of PST on GTP binding
to adipose membranes showed similar characteristics
to those of other PST e¡ects previously described in
rat adipocytes [19], such as the inhibition of insulin-
stimulated glucose transport and lipid synthesis.
Fig. 6. Expression of PLC L isoform proteins in rat adipose
membranes. Rat adipose membranes were denatured and sub-
jected to SDS-PAGE (80 Wg/lane) and immunoblotted as de-
scribed in Section 2.
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These results con¢rm the conclusions raised after in-
direct data obtained from PST binding inhibition
with guanine nucleotides. Besides, PST stimulated
GTP binding was only partially prevented by pertus-
sis toxin pretreatment of adipose membranes, sug-
gesting that both pertussis toxin-sensitive and -insen-
sitive G proteins were involved. Moreover, we
observed that this direct e¡ect of PST stimulating
GTP binding was inhibited mainly by anti-GKq=11
serum and slightly by anti-GKi1;2 serum, whereas
anti-GKo;i3 serum had no e¡ect. These results agree
with the observed e¡ect of pertussis toxin treatment
and suggest a major role of GKq=11 in the signaling of
PST receptor.
Even though we had ruled out an e¡ect of PST on
GKs in rat liver membranes, we wanted to assess the
possible activation of PST on adenylate cyclase ac-
tivity in adipose membranes, which could partly ex-
plain the lipolytic e¡ect in isolated adipocytes [19].
Unlike other lipolytic hormones (glucagon and adre-
naline), PST did not increase cAMP production in
isolated adipose membranes. Nevertheless, an indi-
rect e¡ect on cAMP levels in vivo cannot be ruled
out, since increased [Ca2]i in adipocytes has been
shown to increase cAMP levels [38].
To further elucidate the signal transduction of PST
in the adipocyte, we have studied the main e¡ector
system of GKq=11, i.e. the phospholipase C-L in the
plasma membranes. As previously observed in rat
liver membranes [13], PST dose-dependently stimu-
lated PLC activity. This e¡ect was mediated by
GKq=11 rather than LQ released upon GK1i;2 activa-
tion, in a similar way to that found in rat liver mem-
branes [17]. Besides, PST speci¢cally stimulated
PLC-L3 isoform, in spite of the fact that two other
PLC-L isoforms are present in adipose membranes
(L1 and L2). These data agree with those found in
liver membranes [18]. Besides, previous studies with
other ligands have also described the activation of
PLC-L3 by K-subunits of Gq family [39]. However,
using puri¢ed PLC-L isozymes, it has been found
that PLC-L1 and PLC-L3 may respond about equally
to Kq and K11 [40] whereas PLC-L2 is stimulated to a
much less extent, being preferentially activated by
K16 (another member of the Gq family) [39,41].
Therefore, our data suggest that some speci¢city in
PLC-L isoform activation (PLC-L3) is determined by
PST stimulation of rat adipocyte membranes, as pre-
viously observed in rat liver membranes [18]. These
data suggest that the PLC isoform speci¢city de-
pends on the pancreastatin receptor-G protein sys-
tem, rather than the speci¢c tissue. Previous work
by other authors has also demonstrated speci¢c stim-
ulation of a PLC-L isoenzyme (PLC-L1) by activat-
ing a receptor coupled to a G protein of the GKq
family (angiotensin II) [42]. Regarding PLC-L4,
even though it can also be activated by the GKq
family [43], it is not present in this system.
The PST activation of PLC activity in adipocytes
is expected to increase [Ca2]i and activate protein
kinase C [44,45]. High levels of [Ca2]i, along with
the activation of protein kinase C have been demon-
strated to induce insulin resistance in rat adipocytes
[38,44,46], partly due to increased phosphorylation
of the glucose transporter (GLUT-4). Moreover, cal-
cium has proven to be a second messenger in adipo-
kinetic hormone-induced lipolysis as important as
cAMP [47]. Therefore the PST e¡ect on IP3 produc-
tion may mediate the lipolytic e¡ect of PST previ-
ously observed in isolated adipocytes [19]. On the
other hand, the mechanism of the calcium mediated
antagonism of insulin action may be not so simple,
since another calcium agonist, oxytocin, has a well
known insulin-like e¡ect in the adipocyte [48^50].
Thus, other mechanisms may also play a role in
the lipolytic e¡ect of pancreastatin. In fact, we can-
not rule out an indirect e¡ect of PST on cAMP levels
in the adipocyte, e.g. by inhibiting phosphodiesterase
activity. Further experiments using whole cell sys-
tems may answer this question.
In conclusion, the PST e¡ect on rat adipocyte is
mediated by a high a⁄nity receptor in the plasma
membrane, coupled to a double G protein system.
The pertussis toxin-insensitive GKq=11 protein medi-
ates the speci¢c activation of PLC-L3 in the adipose
membranes.
Acknowledgements
This work was supported by the Fondo de Inves-
tigacio¤n Sanitaria (FIS 96/1411), Ministerio de Sani-
dad (Spain). Carmen Gonza¤lez-Yanes is a recipient
of a fellowship from the Fondo de Investigacio¤n
Sanitaria, Ministerio de Sanidad (Spain) (BEFI 98/
9158)
BBAMCR 14511 30-7-99
C. Gonza¤lez-Yanes et al. / Biochimica et Biophysica Acta 1451 (1999) 153^162160
References
[1] K. Tatemoto, S. Efendic, V. Mutt, G. Makk, G.J. Feistner,
J.C. Barchas, Pancreastatin, a novel pancreatic peptide that
inhibits insulin secretion, Nature 324 (1986) 476^478.
[2] A.L. Iancangelo, H.U. A¡olter, L.E. Eiden, E. Herbert, M.
Grimes, Bovine chromogranin A sequence and distribution
of its messenger RNA in endocrine tissues, Nature 323
(1986) 82^86.
[3] A.L. Iancangelo, R. Fischer-Colbrie, K.J. Koller, M.J.
Brownstein, L.E. Eiden, The sequence of porcine chromog-
ranin A messenger RNA demonstrates chromogranin A can
serve as the precursor for the biologically active hormone,
pancreastatin, Endocrinology 15 (1988) 2339^2341.
[4] N.L. Eskeland, A. Zhou, T.Q. Dihn, H. Wu, R.J. Parmer, E.
Mains, D.T. O’Connor, Chromogranin A processing and
secretion. Speci¢c role of endogenous and exogenous pro-
hormone convertases in the regulated secretory pathway,
J. Clin. Invest. 98 (1996) 148^156.
[5] R.J. Parmer, X.-P. Xi, H.-J. Wu, L.J. Helman, L.N. Petz,
Secretory protein tra⁄c. Chromogranin A contains a domi-
nant targeting signal for the regulated pathway, J. Clin. In-
vest. 92 (1993) 1042^1054.
[6] V. Sa¤nchez-Margalet, M. Lucas, R. Goberna, Pancreastatin:
further evidence for its consideration as a regulatory peptide,
J. Mol. Endocrinol. 16 (1996) 1^8.
[7] V. Sa¤nchez-Margalet, M. Lucas, R. Goberna, Pancreastatin
action in the liver: dual coupling to di¡erent G proteins,
Cell. Signal. 8 (1996) 9^12.
[8] V. Sa¤nchez-Margalet, R. Goberna, Pancreastatin inhibits in-
sulin-stimulated glycogen synthesis but not glycolysis in rat
hepatocytes, Regul. Pept. 51 (1994) 215^220.
[9] V. Sa¤nchez, J.R. Calvo, R. Goberna, Glycogenolytic e¡ect
of pancreastatin in the rat, Biosci. Rep. 10 (1990) 87^91.
[10] V. Sa¤nchez-Margalet, J.R. Calvo, R. Goberna, Glycogeno-
lytic and hyperglycemic e¡ect of 33^49 C-terminal fragment
of pancreastatin in the rat in vivo, Horm. Metab. Res. 34
(1992) 455^457.
[11] V. Sa¤nchez, M. Lucas, J.R. Calvo, R. Goberna, Glycogeno-
lytic e¡ect of pancreastatin in isolated rat hepatocytes is
mediated by a cyclic-AMP-independent Ca2-dependent
mechanism, Biochem. J. 284 (1992) 659^662.
[12] V. Sa¤nchez-Margalet, M. Lucas, R. Goberna, Pancreastatin
increases free cytosolic Ca2+ in rat hepatocytes involving
both pertussis-toxin-sensitive and insensitive mechanisms,
Biochem. J. 294 (1993) 439^442.
[13] V. Sa¤nchez-Margalet, R. Goberna, Pancreastatin activates
pertussis toxin-sensitive guanylate cyclase and pertussis tox-
in-insensitive phospholipase C in rat liver membranes,
J. Cell. Biochem. 55 (1994) 173^181.
[14] V. Sa¤nchez-Margalet, M. Lucas, R. Goberna, Pancreastatin
activates protein kinase C by stimulating the formation of
1,2-diacylglycerol in rat hepatocytes, Biochem. J. 303 (1994)
51^54.
[15] V. Sa¤nchez-Margalet, M. Valle, R. Goberna, Receptors for
pancreastatin in rat liver membranes: molecular identi¢ca-
tion and characterization by covalent cross-linking, Mol.
Pharmacol. 46 (1994) 24^29.
[16] V. Sa¤nchez-Margalet, J. Santos-Alvarez, Solubilization and
molecular characterization of pancreastatin receptors from
rat liver membranes, Endocrinology 138 (1997) 1712^1718.
[17] J. Santos-Alvarez, C. Gonza¤lez-Yanes, V. Sa¤nchez-Margalet,
Pancreastatin receptor is coupled to a GTP binding protein
of the Gq=11K in rat liver membranes, Hepatology 27 (1998)
608^614.
[18] J. Santos-Alvarez, V. Sa¤nchez-Margalet, Pancreastatin acti-
vates L3 isoform of phospholipase C via GK11 protein stim-
ulation in rat liver membranes, Mol. Cell. Endocrinol. 143
(1998) 101^106.
[19] V. Sa¤nchez-Margalet, C. Gonza¤lez-Yanes, Pancreastatin in-
hibits insulin action in rat adipocytes, Am. J. Physiol. 275
(1998) E1055^E1060.
[20] W.M. Hunter, F.C. Greenwood, The preparation of 125I-
labeled human growth hormone of high speci¢c radioactiv-
ity, Nature 19 (1962) 495^496.
[21] M.M. Bradford, A rapid and sensitive method for the quan-
titation of microgram quantities of protein utilizing the prin-
ciple of protein-dye binding, Anal. Biochem. 72 (1976) 248^
254.
[22] C.D. Smith, R.J. Uhing, R. Snyderman, Nucleotide regula-
tory protein-mediated activation of phospholipase C in hu-
man polymorphonuclear leukocytes is disrupted by phorbol
esters, J. Biol. Chem. 262 (1987) 6121^6127.
[23] V. Sa¤nchez-Margalet, C. Gonza¤lez-Yanes, J. Santos-Alvarez,
S. Najib, Insulin activates GKi1;2 protein in rat hepatoma
(HTC) plasma membranes, Cell. Mol. Life Sci. 55 (1999)
142^147.
[24] J. Santos-Alvarez, V. Sa¤nchez-Margalet, G protein GKq=11
and GKi1;2 are activated by pancreastatin receptors in rat
liver. Studies with GTP-Q-35S and azido-GTP-K-32P, J. Cell.
Biochem. (1999) in press.
[25] A. Al-Aoukaty, T.J. Schall, A.A. Maghazachi, Di¡erential
coupling of CC chemokine receptors to multiple heterotri-
meric G proteins in human interleukin-2-activated natural
killer cells, Blood 87 (1996) 4255^4260.
[26] C. Jouneaux, A. Mallat, C. Serradail-Le Gal, P. Goldsmith,
J. Hanoune, S. Lotersztajn, Coupling of endothelin B recep-
tors to the calcium pump and phospholipase C via Gs and
Gq in rat liver, J. Biol. Chem. 269 (1994) 1845^1851.
[27] A. Shenker, P. Goldsmith, C.G. Unson, A.M. Spiegel, The
G protein coupled to the thromboxane A2 receptor in hu-
man platelets is a member of the novel Gq family, J. Biol.
Chem. 266 (1991) 9309^9313.
[28] J.R. Schelling, N. Nkemere, M. Konieczkowski, K.A. Mar-
tin, G.R. Dubyak, Angiotensin II activates the L1 isoform of
phospholipase C in vascular smooth muscle cells, Am.
J. Physiol. 272 (1997) C1558^C1566.
[29] V. Sa¤nchez-Margalet, I.D. Gold¢ne, K. Truitt, J. Imboden,
C.K. Sung, Role of p85 subunit of phosphatidylinositol-3-
kinase as an adaptor molecule linking the insulin receptor to
insulin receptor substrate 1, Mol. Endocrinol. 9 (1995) 435^
442.
BBAMCR 14511 30-7-99
C. Gonza¤lez-Yanes et al. / Biochimica et Biophysica Acta 1451 (1999) 153^162 161
[30] S. Gutowski, A. Smrcka, L. Nowak, D. Wu, M. Simon, P.C.
Sternweis, Antibodies to the Kq subfamily of guanine nu-
cleotide-binding regulatory protein K subunits attenuate ac-
tivation of phosphatidylinositol 4,5-bisphosphate hydrolysis
by hormones, J. Biol. Chem. 266 (1991) 20519^20524.
[31] V. Sa¤nchez-Margalet, R. Goberna, Pancreastatin, a new pep-
tide associated with essential hypertension and hyperinsuli-
nemia, in: M.M. Galteau, J. Henny, G. Siest (Eds.), Biologic
Prospective, Libbey, Paris, 1993, pp. 575^580.
[32] V. Sa¤nchez-Margalet, J. Santos-Alvarez, R. Goberna, Pan-
creastatin signaling in the liver, in: Neurochemistry: Cellu-
lar, Molecular and Clinical Aspects, Plenum, New York,
1997, pp. 589^593.
[33] V. Sa¤nchez-Margalet, Modulation of insulin receptor signal-
ling by pancreastatin in HTC hepatoma cells, Diabetologia
42 (1999) 317^325.
[34] A. Funakoshi, K. Tateishi, H. Shinozaki, M. Matsumoto, H.
Wakasugi, Elevated plasma levels of pancreastatin (PST) in
patients with non-insulin-dependent diabetes mellitus
(NIDDM), Regul. Pept. 30 (1990) 159^164.
[35] V. Sa¤nchez-Margalet, J.A. Lobo¤n, A. Gonzalez, F. Escobar-
Jimenez, R. Goberna, Increased plasma pancreastatin-like
levels in gestational diabetes subjects. Correlation with plas-
ma catecholamine levels, Diabetes Care 21 (1998) 1951^1954.
[36] V. Sa¤nchez-Margalet, M. Valle, J.A. Lobo¤n, A. Maldonado,
F. Escobar, J. Oliva¤n, R. Perez-Cano, R. Goberna, In-
creased plasma pancreastatin-like immunoreactivity levels
in non-obese patients with essential hypertension, J. Hyper-
tens. 13 (1995) 251^258.
[37] V. Sa¤nchez-Margalet, M. Valle, J.A. Lobo¤n, F. Escobar-Ji-
menez, R. Perez-Cano, R. Goberna, Plasma pancreastatin-
like immunoreactivity correlates with plasma norepinephrine
levels in essential hypertension, Neuropeptides 29 (1995) 97^
101.
[38] N. Begum, K.E. Sussman, B. Draznin, Calcium-induced in-
hibition of phosphoserine phosphatase in insulin target cells
is inhibited by the phosphorylation and activation of inhib-
itor 1, J. Biol. Chem. 267 (1992) 5959^5963.
[39] J.H. Exton, Regulation of phosphoinositide phospholipases
by hormones, neurotransmitters, and other agonists linked
to G proteins, Annu. Rev. Pharmacol. Toxicol. 36 (1996)
481^509.
[40] J.R. Hepler, T. Kozasa, A.V. Smrcka, M.I. Simon, S.G.
Rhee, P.C. Sternweis, A.G. Gilman, Puri¢cation from Sf9
cells and characterization of recombinant GqK and G11K.
Activation of phospholipase C isoenzymes by GK subunits,
J. Biol. Chem. 268 (1993) 14367^14375.
[41] C.H. Lee, D. Park, D. Wu, S.G. Rhee, M.I. Simon, Mem-
bers of the GqK subunit gene family activate phospholipase
C L isozymes, J. Biol. Chem. 267 (1992) 16044^16047.
[42] J.R. Schelling, N. Nkemere, M. Konieczkowski, K.A. Mar-
tin, G.R. Dubyak, Angiotensin II activates the L1 isoform of
phospholipase C in vascular smooth muscle cells, Am.
J. Physiol. 272 (1997) C1558^C1566.
[43] H. Jiang, D. Wu, M.I. Simon, Activation of phospholipase
C L4 by heterotrimeric GTP-binding proteins, J. Biol. Chem.
269 (1994) 7593^7596.
[44] Z. Ni, M. Smogorzewski, S.G. Massry, E¡ects of parathy-
roid hormone on cytosolic calcium of rat adipocytes, Endo-
crinology 135 (1994) 1837^1844.
[45] M.J. Berridge, Inositol triphosphate and diacylglycerol: two
interacting second messengers, Annu. Rev. Biochem. 56
(1987) 159^193.
[46] J.E.-B. Reusch, N. Begum, K.E. Sussman, B. Draznin, Reg-
ulation of GLUT-4 phosphorylation by intracellular calcium
in adipocytes, Endocrinology 129 (1991) 3269^3273.
[47] E.L. Arrese, M.T. Flowers, J.L. Gazard, M.A. Wells, Cal-
cium and cAMP are second messengers in the adipokinetic
hormone-induced lipolysis of triacylglycerols in manduca
sexta fat body, J. Lipid Res. 40 (1999) 556^564.
[48] H.J. Goren, K. Hanif, R. Dudley, M.D. Hollenberg, K.
Lederis, Adenosine modulation of fat cell responsiveness to
insulin and oxytocin, Regul. Pept. 16 (1986) 125^134.
[49] H.M. Lee, J.N. Fain, Regulation of oxytocin-induced phos-
phoinositide breakdown in adipocytes by adenosine, isopro-
terenol and insulin, Biochim. Biophys. Acta 1013 (1989) 73^
79.
[50] K.L. Kelly, J.T. Deeney, B.E. Corkey, Cytosolic free calcium
in adipocytes. Distinct mechanisms of regulation and e¡ects
on insulin action, J. Biol. Chem. 264 (1989) 12754^12757.
BBAMCR 14511 30-7-99
C. Gonza¤lez-Yanes et al. / Biochimica et Biophysica Acta 1451 (1999) 153^162162
